PathAI Announces Poster Presentations at the 2025 American Association of Cancer Research Annual Meeting

BOSTON, April 21, 2025 (GLOBE NEWSWIRE) — PathAI, a global leader in AI-powered pathology solutions, today announced it will present research from the outputs of PathAI’s pathology universal transformer (PLUTO) foundation model and portfolio of oncology products at the American Association of Cancer Research (AACR) Annual Meeting being held from April 25–30, 2025, in Chicago, IL.

The data to be presented demonstrate the power of PathAI’s pathology universal transformer (PLUTO) foundation model to anchor models that predict oncogenic molecular driver alterations from routine hematoxylin and eosin (H&E)-stained whole slide images (WSIs). These presentations also highlight PathExplore1, PathAI’s AI-powered panel of histopathology features that spatially characterize the tumor microenvironment (TME) with single-cell resolution.These novel findings illustrate the potential of PathAI’s AI models to facilitate screening of patient samples for clinical trials.

Poster Details

Session: Artificial Intelligence for Digital Pathology and Spatial Molecular Technologies
Section: 45

Title: AI-powered approaches accurately predict t(11;14) positive multiple myeloma from H&E-stained histologic sections by identifying regions demonstrating lymphoplasmacytic cytology (Abstract Number 2425 / 10)

  • Presenter: Lara Murray, Ph.D., Senior Translational Science Lead, PathAI
  • Date and Time: Monday, April 28, 2025, from 9:00 a.m. – 12:00 p.m. CT

Title: Artificial intelligence enables prediction of MET amplification & associated morphologic features from H&E-stained NSCLC specimens (Abstract Number 2430 / 15 )

  • Presenter: Ylaine Gerardin, Ph.D., Principal Biomedical Data Scientist, PathAI
  • Date and Time: Monday, April 28, 2025, from 9:00 a.m. – 12:00 p.m. CT

Follow PathAI on LinkedIn for more updates from the AACR Annual Meeting and visit our team at booth #4133.

About PathAI

PathAI is a leading provider of integrated AI and digital pathology solutions dedicated to transforming diagnostic accuracy and operational efficiency in pathology labs worldwide. Through innovative technologies and strategic partnerships, PathAI aims to enhance patient outcomes and drive the future of medical diagnostics. For more information, please visit www.pathai.com.

Footnote

1PathExplore is For Research Use Only. Not for use in diagnostic procedures.

Company Contact
Elizabeth Storti
elizabeth.storti@pathai.com

Media Contact
Daniel Donato
LifeSci Communications
ddonato@lifescicomms.com

Staff

Recent Posts

MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi

KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat…

3 hours ago

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education. …

3 hours ago

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose…

3 hours ago

How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist

Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards,…

3 hours ago

Facelift + Eyelid Surgery in Tampa: Gruber Plastic Surgery Shares 2025 Planning Insights on Natural Results and Popular Procedure Pairings

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national…

3 hours ago

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…

6 hours ago